Test kit from Turkey to 50 countries! Became the country sending private aircraft

gave | Saturday, May 15, 2021 – 17:55 | Last Updated: 15 05 2021 – 17:55

The company’s COVID-19 test kits of the company, which started R & D as soon as the new coronavirus epidemic occurred in China, are exported to 50 countries in the world, especially European countries such as England, Italy and France. Stating that they brought about 50 million dollars in foreign currency to Turkey in 2020, Anatolia Tanı A.Ş., Chairman of the Board of Directors, Alper Akyüz said, “We have established a new and much larger R&D center with an investment of 80 million lira. we will continue, “he said.

Anatolia Tanı A.Ş., which predicts that the coronavirus can affect the world after its emergence in China and exported the first coronavirus test kit to Italy in February 2020, became one of the first companies in the world to develop and produce this test kit. In the past year, the company has expanded to 15 countries in more than 50 countries including Italy, England, France, Poland, Ukraine, Portugal, Bangladesh, United Arab Emirates, Pakistan, Argentina, South Africa, Turkmenistan, Jordan, Egypt, Canada, Georgia and Iraq. Exported more than a million isolation and test kits.


Stating that the company has produced more than 300 kits that detect more than 130 pathogens under the brand of Anatolia Geneworks, Anatolia Tanı A.Ş., Chairman of the Board of Directors, Alper Akyüz said, “With the coronavirus epidemic, the areas in which the kits are used and their importance in terms of human health have been better understood. Our R&D on coronavirus started at the end of 2019. We started our preparations on the ‘mysterious disease’ news from China. We realized that this could turn into a pandemic in a short time. Then, we sent our first test kit to Italy in February 2020. Later, we received requests from many European countries, “he said.

Explaining that the kits are delivered to countries in need from Turkey, Alper Akyüz said, “The Polish Ministry of Health sent a special plane to our country to buy the kits. We have been offering our products in various hospitals and laboratories in Turkey for a long time. Our products are used in the hospital and are exported to more than 50 different countries. “We continue our sales in a wide area around the world. We have sold over 15 million tests in terms of Real-Time PCR kit and isolation kit. As a result, we earned more than $ 50 million in foreign currency in 2020 in Turkey.”


Stating that the need for test kits may continue for many years, Akyüz informed that they have established a new and much larger R&D center with an investment of 80 million TL. Akyüz said, “We maintain a similar pace in 2021. Although the vaccination studies continue to gain speed, the need for testing is not over. Our test kit production will continue to increase in the coming years. The need seems to continue for many years. We are here to meet this demand. We are working with our strength. Our number of employees has increased a lot over the years. We currently have more than 100 personnel, 35 of which are in our R&D center. We will move to our new R&D center in the coming months. We hope that we will be able to work with many more researchers here, “he said.


Alper Akyüz, who mentioned that some PCR test kits give erroneous results recently, said, “The probability of a well-designed and manufactured PCR kit is one hundred percent. There is no possibility of missing a positive case in any way. However, it is worth mentioning that each kit is unique. There is a sensitivity limit. If the viral load on the person is below this, the kit may not be able to detect it. Apart from these, some negative effects that may occur during sampling from the person, storage conditions of the kit, and problems encountered during application may cause undesirable results.

Anatolia Geneworks R&D Director and co-founder Molecular Biologist Dr. Elif Akyüz, on the other hand, explained that they developed 12 new coronavirus kits upon requests from various countries and said:

“We have kits to detect infectious diseases such as hepatitis, AIDS, COVID-19, malaria, tuberculosis, and hereditary diseases such as familial Mediterranean fever. We realized that the virus was spreading rapidly. We decided to develop a kit that detected the virus. We became one of the first companies to put the kit into use in February 2020. Both our R&D team and our production team worked devotedly and intensively to meet the demand. We have developed 12 new coronavirus kit versions in response to the demands. “